Neuro-Edu
-
Update on the Diagnosis, Standard of Care and New Treatments for Duchenne Muscular Dystrophy
Program Director: Basil Darras, MD
Program Sponsor: Sarepta Therapeutics, PTC Therapeutics and NS Pharma AMA PRA Category 1TM accredited continuing medical education series of six (6) unique educational presentations Available March 24, 2023 through March 23, 2025 -
The Clinical Features, Diagnosis, and Treatment of Hypersomnia Disorders
Program Director: Michael Thorpy, MD
Program Sponsor: Harmony Biosciences AMA PRA Category 1TM accredited continuing medical education series of seven (7) unique educational presentations Available September 23, 2022 to September 23, 2024 -
Diagnosis and Treatment of Amyloid Disorders
Program Director: Thomas H. Brannagan, III, MD
Program Sponsor: Alnylam Pharmaceuticals AMA PRA Category 1TM accredited continuing medical education series of seven (7) unique educational presentations Available November 30, 2021 to November 29, 2023 -
Immunopathogenesis and Advances on Immunotherapies in Autoimmune Neuromuscular Diseases
Program Directors: Marinos Dalakas, MD, and Norman Latov, MD, PhD
Program Sponsor: argenx AMA PRA Category 1TM accredited continuing medical education series of three (3) unique educational presentations Available October 15, 2021 to October 24, 2023 -
Diagnosis and Treatment of Immune Mediated Neuromuscular Disease and Targeted Immune Therapies
Program Directors: Marinos Dalakas, MD, and Norman Latov, MD, PhD
Program Sponsor: Alexion Pharmaceuticals AMA PRA Category 1TM accredited continuing medical education series of four (4) unique educational presentations Available August 31, 2021 to August 20, 2023 -
Differential Diagnosis and Treatment of Immune Mediated Demyelinating Neuropathies
Program Directors: Norman Latov, MD, PhD, and Marinos Dalakas, MD
Program Sponsor: Takeda Pharmaceuticals, USA AMA PRA Category 1TM accredited continuing medical education series of five (5) unique educational presentations Available March 10, 2021 to March 9, 2023
